Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.2M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
20.5M
-
Shares change
-
+1.26M
-
Total reported value, excl. options
-
$694M
-
Value change
-
+$36.7M
-
Put/Call ratio
-
1.32
-
Number of buys
-
66
-
Number of sells
-
-76
-
Price
-
$33.84
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) as of Q2 2021
186 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share as of Q2 2021.
Arcturus Therapeutics Holdings Inc. - Common Stock, par value $0.001 per share (ARCT) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.5M shares
of 27.2M outstanding shares and own 75.49% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (3.03M shares), ARK Investment Management LLC (2.88M shares), STATE STREET CORP (1.76M shares), BlackRock Inc. (1.7M shares), Nikko Asset Management Americas, Inc. (1.21M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.21M shares), VANGUARD GROUP INC (1.18M shares), ORBIMED ADVISORS LLC (849K shares), FMR LLC (730K shares), and Bank Julius Baer & Co. Ltd, Zurich (703K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.